![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Population Pharmacokinetics of Sofosbuvir and Its Major Metabolite (GS-331007)
in Healthy and HCV-Infected Adult Subjects
|
|
|
Reported by Jules Levin
AASLD 2013 November 1-5, Washington, DC
Brian Kirby,1 Toufigh Gordi,2 William T. Symonds,1 Brian P. Kearney,1 Anita Mathias1
1Gilead Sciences, Inc., Foster City, CA; 2Rosa & Co. LLC, San Carlos, CA
![AASLD1.gif](../../2015/images/122115/122115-10/AASLD1.gif)
![AASLD2.gif](../../2015/images/122115/122115-10/AASLD2.gif)
![AASLD3.gif](../../2015/images/122115/122115-10/AASLD3.gif)
![AASLD4.gif](../../2015/images/122115/122115-10/AASLD4.gif)
![AASLD5.gif](../../2015/images/122115/122115-10/AASLD5.gif)
![AASLD6.gif](../../2015/images/122115/122115-10/AASLD6.gif)
![AASLD7.gif](../../2015/images/122115/122115-10/AASLD7.gif)
![AASLD8.gif](../../2015/images/122115/122115-10/AASLD8.gif)
![AASLD9.gif](../../2015/images/122115/122115-10/AASLD9.gif)
![AASLD10.gif](../../2015/images/122115/122115-10/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|